The impact of the presence of youngsters on grownup smoking behaviour: empirical proof primarily based on China household panel research
Background: Regardless of various research linking household and marriage components with well being behaviour, the consequences of youngsters on the well being behaviour of oldsters are nonetheless understudied. This research explored the affiliation between the presence of youngsters and adults’ smoking behaviours.
Strategies: This research used panel information from the China Household Panel Research 2010 and 2012, and the info set included 23,157 households and 45,513 adults. Logistic regression was carried out to analyse the affiliation of the presence of youngsters on adults’ smoking behaviours. Subgroup regression was used to look at heterogeneous results.
Outcomes: Full pattern regressions confirmed that the variety of youngsters was considerably inversely related to smoking behaviour (OR = 0.93; 95% 0.90-0.96). Additional subsample regression finds that such impact is barely vital among the many high-education group (OR = 0.92; 95% 0.87-0.97), high-skill staff (OR = 0.89; 95% 0.80-0.99) and {couples} who had an age hole better than 2 years (OR = 0.91; 95% 0.88-0.95).
Conclusions: Our findings verify the existence of the upward intergenerational impact of the presence of youngsters on adults’ smoking behaviour in China. Nonetheless, such results will not be equal throughout all demographic traits. Future analysis may discover different elements of the upward mechanism and potential pathways for a stronger impact. In resource-poor areas, focusing on cessation actions at those that have youngsters at an early age could also be an efficient technique.
Mouse Monoclonal Anti-Gardasil vaccine L1s (Human Papilloma Virus/HPV6+11+16+18 late proteins) antiserum control for ELISA |
|||
HPV618L13-S | Alpha Diagnostics | 1 ml | 562.8 EUR |
Rabbit Anti-Gardasil vaccine (merck) antiserum (Human Papilloma Virus 16+18 (HPV16/18) late proteins L1 (HPV16+18L1) control for ELISA |
|||
HPV16181-S | Alpha Diagnostics | 500 ul | 562.8 EUR |
Labcold Gel Pack for Vaccine Transport Bag |
|||
REF4120 | Scientific Laboratory Supplies | EACH | 5.26 EUR |
Human Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgG antiserum negative control |
|||
970-360-01N | Alpha Diagnostics | 1 ml | 196.8 EUR |
Human Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgG antiserum positive control |
|||
970-360-02P | Alpha Diagnostics | 1 ml | 270 EUR |
Human Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgM antiserum negative control |
|||
970-370-01N | Alpha Diagnostics | 1 ml | 196.8 EUR |
Human Anti-Merozoite surface protein-1 (MSP-1; P. falciparum/malaria vaccine) IgM antiserum positive control |
|||
970-370-02P | Alpha Diagnostics | 1 ml | 270 EUR |
Labcold Rigid Cool Block for Vaccine Transport Bag |
|||
REF4122 | Scientific Laboratory Supplies | EACH | 19.88 EUR |
Recombinant flagellin FlicC vaccine adjuvant (TLR5 agonist); vaccine adjuvant |
|||
AV-7010-50 | Alpha Diagnostics | 50 ug | 1074 EUR |
Bordetella bronchiseptica proteins (inactivated vaccine for dog) for ELISA |
|||
BBV15-N-100 | Alpha Diagnostics | 100 ug | 343.2 EUR |
Saponin Vaccine Adjuvant |
|||
VAdv-Ly0009 | Creative Biolabs | 1 g | 1314 EUR |
Description: Saponin Vaccine Adjuvant, plant-based vaccine adjuvant. |
|||
Rabbit Anti-West Nile Virus vaccine (WNV, Recombitek/DNA vaccine) antiserum |
|||
WNV13-S | Alpha Diagnostics | 100 ul | 548.4 EUR |
SARS-CoV-2 Spike RBD ELISA Kit (For Vaccine Development) |
|||
RAS-A050 | ACROBIOSYSTEMS | 96tests | 631.3 EUR |
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike Protein RBD is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
Labcold Trolley for Use with 20L/30L Vaccine Transport Bags |
|||
REF4118 | Scientific Laboratory Supplies | EACH | 254.59 EUR |
Peanut Oil vaccine adjuvant |
|||
AV-5010-50 | Alpha Diagnostics | 50 ml | 270 EUR |
Rabies virus Glycoprotein G ELISA Kit (For Vaccine Development) |
|||
RAS-A167 | ACROBIOSYSTEMS | 96tests | 631.3 EUR |
Description: Rabies virus (RABV), scientific name Rabies lyssavirus, is a deadly neurotropic virus that causes rabies in humans and animals. Rabies virus has an extremely wide host range and its transmission most often occur through the saliva of animals. Without intervention prior to disease progression, rabies has the highest case fatality of any infectious disease. RABV contains a single-stranded negative-sense R genome that encodes five structural proteins: nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein (G), and R-dependent R polymerase (L). Among these viral proteins, the RABV glycoprotein (RABV-G) is a pivotal player mediating virus entry and the major target of neutralizing antibodies, thus a key factor for vaccine and drug design.A rapid and effective assay kit detecting the levels ofRABV-G is urgently needed to accelerate the development of RABV vaccines. |
|||
Mineral Oil vaccine adjuvant |
|||
AV-5020-50 | Alpha Diagnostics | 50 ml | 270 EUR |
SARS-CoV-2 Spike Protein ELISA Kit (For Vaccine Development) |
|||
RAS-A039 | ACROBIOSYSTEMS | 96tests | 631.3 EUR |
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
HS15 Kolliphore vaccine adjuvant |
|||
AV-6010-100 | Alpha Diagnostics | 100 g | 343.2 EUR |
Calcium phosphate vaccine adjuvant |
|||
AV-1020-100 | Alpha Diagnostics | 100 ml | 262.8 EUR |
Pam2CSK4 vaccine adjuvant; Biotin conjugate |
|||
AV-9020-B | Alpha Diagnostics | 1 mg | 489.6 EUR |
Pam2CSK4 vaccine adjuvant; Biotin conjugate |
|||
AV-9020-B-100 | Alpha Diagnostics | 100 ug | 196.8 EUR |
Mannide monooleate vaccine adjuvant |
|||
AV-5030-5 | Alpha Diagnostics | 5 g | 196.8 EUR |
Pam2CSK4 vaccine adjuvant, unlabeled |
|||
AV-9020-1 | Alpha Diagnostics | 1 mg | 489.6 EUR |
Pam3CSK4 vaccine adjuvant, unlabeled |
|||
AV-9025-1 | Alpha Diagnostics | 1 mg | 343.2 EUR |
Labcold Vaccine Transport Bag 3L |
|||
REF4110 | Scientific Laboratory Supplies | EACH | 168 EUR |
SARS-CoV-2 Spike RBD (XBB.1.5) ELISA Kit (For Vaccine Development) |
|||
RAS-A146 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike RBD is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
RWJ 21757 Synthetic vaccine adjuvant |
|||
AV-9010-1 | Alpha Diagnostics | 1 mg | 196.8 EUR |
RWJ 21757 Synthetic vaccine adjuvant |
|||
AV-9010-5 | Alpha Diagnostics | 5 mg | 343.2 EUR |
Labcold Vaccine Transport Bag 10L |
|||
REF4112 | Scientific Laboratory Supplies | EACH | 222 EUR |
Labcold Vaccine Transport Bag 20L |
|||
REF4114 | Scientific Laboratory Supplies | EACH | 276 EUR |
Labcold Vaccine Transport Bag 30L |
|||
REF4116 | Scientific Laboratory Supplies | EACH | 381.6 EUR |
SARS-CoV-2 Spike Trimer (XBB.1.5) ELISA Kit (For Vaccine Development) |
|||
RAS-A145 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike Trimer is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
SARS-CoV-2 Spike Trimer (XBB.1) ELISA Kit (For Vaccine Development) |
|||
RAS-A149 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike Trimer is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
Core Panel Multi-Tumor control slides, set of 5 |
|||
TS900 | Innovex | Set of 5 | 145 EUR |
Description: Core Panel Multi-Tumor control slides, set of 5 |
|||
Core Panel Multi-Tumor control slides, set of 25 |
|||
TS900-25 | Innovex | Set of 25 | 425 EUR |
Description: Core Panel Multi-Tumor control slides, set of 25 |
|||
Breast Panel Multi-Tumor control slides, set of 5 |
|||
TS901 | Innovex | Set of 5 | 145 EUR |
Description: Breast Panel Multi-Tumor control slides, set of 5 |
|||
Breast Panel Multi-Tumor control slides, set of 25 |
|||
TS901-25 | Innovex | Set of 25 | 395 EUR |
Description: Breast Panel Multi-Tumor control slides, set of 25 |
|||
Pam3CSK4 vaccine adjuvant; FITC labelled |
|||
AV-9025-F | Alpha Diagnostics | 100 ug | 416.4 EUR |
Pertussis Toxin B.Pertussis, vaccine grade |
|||
AV-9130-50 | Alpha Diagnostics | 50 ug | 634.8 EUR |
Peptidoglycan (S. aureus); vaccine adjuvant |
|||
AV-7045-25 | Alpha Diagnostics | 25 mg | 1220.4 EUR |
Peptidoglycan (S. aureus); vaccine adjuvant |
|||
AV-7045-5 | Alpha Diagnostics | 5 mg | 343.2 EUR |
SARS-CoV-2 Spike S1 (B.1.1.529) Specific ELISA Kit (For Vaccine Development) |
|||
RAS-A170 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike S1 is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
Pam3CSK4 vaccine adjuvant; Biotin labelled |
|||
AV-9025-B | Alpha Diagnostics | 100 ug | 416.4 EUR |
SARS-CoV-2 Spike RBD (B.1.1.529) Specific ELISA Kit (For Vaccine Development) |
|||
RAS-A082 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
SARS-CoV-2 Spike RBD (B.1.617.2) Specific ELISA Kit (For Vaccine Development) |
|||
RAS-A092 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
SARS-CoV-2 Spike Trimer (B.1.617.2) Specific ELISA Kit (For Vaccine Development) |
|||
RAS-A055 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
SARS-CoV-2 Spike Trimer (B.1.1.529) Specific ELISA Kit (For Vaccine Development) |
|||
RAS-A081 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
SARS-CoV-2 Spike Trimer (BA.4) Specific ELISA Kit (For Vaccine Development) |
|||
RAS-A124 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
SARS-CoV-2 Spike Trimer (BA.5) Specific ELISA Kit (For Vaccine Development) |
|||
RAS-A125 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
SARS-CoV-2 Spike RBD (Wild Type) Specific ELISA Kit (For Vaccine Development) |
|||
RAS-A116 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
Varicella Zoster Virus Glycoprotein E (VZV gE) ELISA Kit (For Vaccine Development) |
|||
RAS-A135 | ACROBIOSYSTEMS | 96tests | 631.3 EUR |
Description: Varicella-zoster virus (VZV) the etiologic agent of chickenpox and herpes zoster [HZ], is highly contagious and still endemic worldwide. Glycoprotein E (gE) is one of the known glycoproteins (gB, gC, gE, gH, gI, gK, gI) of VZV that is most abundantly expressed on the surface of virus and infected cells, playing an important role in viral replication and cell-to-cell spread. The strongly immunogenic gE can provide strong IgG signal in body fluid, which makes it ideal to be developed as an antigen for analysis of Immunogenicity in the development of VZV vaccine.Therefore,It's helpful to develop the Varicella Zoster Virus Glycoprotein E (VZV gE) ELISA Kit to quantitative detection the VZV gE antigen in vaccine samples during the manufacture and quality control of vaccine development. |
|||
HRSV (A) Pre-Fusion glycoprotein F0 Specific ELISA Kit (For Vaccine Development) |
|||
RAS-A163 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
Description: Respiratory syncytial virus (RSV) is a highly contagious virus causing severe infection in infants and the elderly. Various approaches are being used to develop an effective RSV vaccine. The RSV fusion (F) subunit, particularly the cleaved trimeric pre-fusion F, is one of the most promising vaccine candidates under development.A rapid and effective assay kit detecting the levels of HRSV (A) Pre-Fusion glycoprotein F0 is urgently needed to accelerate the development of RSV vaccines. |
|||
HRSV (A) Post-Fusion glycoprotein F0 Specific ELISA Kit (For Vaccine Development) |
|||
RAS-A169 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
Description: Most in vitro RSV neutralizing antibodies in human sera are directed against the prefusion conformation, but due to its instability the prefusion conformation has a propensity to prematurely refold into the stable postfusion conformation, both in solution and on the surface of the virions. An RSV F protein that has both high expression levels and maintains a stable prefusion conformation would, therefore, be a promising subunit vaccine candidate against RSV. To facilitate the RSV-related research, drug trials and vaccine development,a rapid and effective assay kit detecting the specific levels of HRSV (A) Post-Fusion glycoprotein F0 is urgently needed to accelerate the development of RSV vaccines. |
|||
HER2 peptide, (369 ?377), E75 vaccine candidate |
|||
HER2-369-P | Alpha Diagnostics | 5 mg | 416.4 EUR |
HER2 peptide, (654 ? 662), GP2 vaccine candidate |
|||
HER2-654-P | Alpha Diagnostics | 5 mg | 416.4 EUR |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to West Nile Virus vaccines (WNV-ENV/NS1/prM) vaccine by ELISA |
|||
910-360-CUX | Alpha Diagnostics | Custom | Ask for price |
Mouse Anti-Her2 Protein (ECD) ELISA kit for Her2 vaccine, 96 tests, Quantitative |
|||
200-620-HRH | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Purified Cholera Toxin protein; vaccine grade |
|||
AV-9135-1000 | Alpha Diagnostics | 1 mg | 781.2 EUR |
Purified Cholera Toxin protein; vaccine grade |
|||
AV-9135-500 | Alpha Diagnostics | 500 ug | 416.4 EUR |
SARS-CoV-2 Spike Trimer (Wild Type) Specific ELISA Kit (For Vaccine Development) |
|||
RAS-A115 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
Labcold 543L Pharmacy and Vaccine Refrigerator |
|||
RLDF1819 | Scientific Laboratory Supplies | EACH | 4623.6 EUR |
SARS-CoV-2 Spike RBD (BA.4 & BA.5) Specific ELISA Kit (For Vaccine Development) |
|||
RAS-A126 | ACROBIOSYSTEMS | 96tests | 845.3 EUR |
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
NATtrol Flu Verification Panel (7 X 0.5 mL) |
|||
NATFVP-NNS | Zeptometrix | 7 X 0.5 mL | 417 EUR |
Vet-SAP Vaccine adjuvant, (EU GMP grade) >95%; |
|||
AV-4020-100 | Alpha Diagnostics | 100 mg | 196.8 EUR |
Vet-SAP Vaccine adjuvant, (EU GMP grade) >95%; |
|||
AV-4020-1000 | Alpha Diagnostics | 1 g | 634.8 EUR |
Zika Virus (ZIKV) Envelop protein ELISA kit for vaccine testing, 48 tests, Quantitative |
|||
RV-403001-ENV-48 | Alpha Diagnostics | 1 Kit | 1000.8 EUR |
Human Anti-Her2 Protein (ECD) IgG ELISA kit for Her2 vaccine, 96 tests, Quantitative |
|||
200-600-HRH | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Human Anti-Her2 Protein (ECD) IgM ELISA kit for Her2 vaccine, 96 tests, Quantitative |
|||
200-610-HRM | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Mouse Anti-Her2 Protein (ECD) IgM ELISA kit for Her2 vaccine, 96 tests, Quantitative |
|||
200-630-HRM | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Human Anti-Human Chorionic Gonadotropin (HCG) IgG ELISA kit for HCG Vaccine, 96 tests |
|||
500-300-HHG | Alpha Diagnostics | 1 kit | 854.4 EUR |
Mouse Anti-Human Chorionic Gonadotropin (HCG) IgG ELISA kit for HCG Vaccine, 96 tests |
|||
500-330-HRG | Alpha Diagnostics | 1 kit | 854.4 EUR |
HER2 multi peptide, (776-790,927-941,1116-1180); vaccine candidate |
|||
HER2-MP2 | Alpha Diagnostics | 5 mg | 781.2 EUR |
HER2 multi peptide, (42-56,98-114,328-345); vaccine candidate |
|||
HER2-MP3 | Alpha Diagnostics | 5 mg | 634.8 EUR |
Complete Freund?s Adjuvant (CFA);vaccine adjuvant |
|||
AV-3010-10 | Alpha Diagnostics | 10 ml | 343.2 EUR |
Complete Freund?s Adjuvant (CFA);vaccine adjuvant |
|||
AV-3010-100 | Alpha Diagnostics | 10x10 ml | 489.6 EUR |
Rabbit Anti-Human Chorionic Gonadotropin (HCG) IgG ELISA kit for HCG Vaccine, 96 tests |
|||
500-320-HMG | Alpha Diagnostics | 1 kit | 854.4 EUR |
Zika Virus NS1 (ZIKV-NS1) protein ELISA kit for vaccine testing, 96 tests, Quantitative |
|||
RV-403301-NS1-48 | Alpha Diagnostics | 1 Kit | 1000.8 EUR |
Yellow Fever Vaccine Serum: 12-Month (IgG) Bleed |
|||
SER71209-1000 | The Native Antigen Company | 1ml | 542.2 EUR |
Yellow Fever Vaccine Serum: 12-Month (IgG) Bleed |
|||
SER71209-500 | The Native Antigen Company | 0.5ml | 354.66 EUR |
Incomplete Freund?s Adjuvant (IFA);vaccine adjuvant |
|||
AV-3015-10 | Alpha Diagnostics | 10 ml | 343.2 EUR |
Incomplete Freund?s Adjuvant (IFA);vaccine adjuvant |
|||
AV-3015-100 | Alpha Diagnostics | 10x10 ml | 489.6 EUR |
Recombinant CDV H Protein (aa 1-607) (strain Convac vaccine) |
|||
VAng-Lsx04670-inquire | Creative Biolabs | inquire | Ask for price |
Description: Canine distemper virus (strain Convac vaccine) Hemagglutinin glycoprotein, recombinant protein. |
|||
HER2 multi peptide, (369-386, 688-703,971-984); vaccine candidate |
|||
HER2-MP1 | Alpha Diagnostics | 5 mg | 634.8 EUR |
EcoCRM Diptheria Toxin Mutant Vaccine Carrier Protein |
|||
1601-001 | IBT Bioservices | 1mg | 363.6 EUR |
Description:
|
|||
Rabbit Anti-Bordetella bronchiseptica vaccine antiserum |
|||
BBV11-S | Alpha Diagnostics | 100 ug | 562.8 EUR |
Yellow Fever Virus Vaccine Serum: 2 Week (IgM) Bleed |
|||
SER71201-1000 | The Native Antigen Company | 1ml | 542.2 EUR |
Yellow Fever Virus Vaccine Serum: 2 Week (IgM) Bleed |
|||
SER71201-500 | The Native Antigen Company | 0.5ml | 354.66 EUR |
Yellow Fever Virus Vaccine Serum: 6 Week (IgG) Bleed |
|||
SER71202-100 | The Native Antigen Company | 0.1ml | 315.25 EUR |
Yellow Fever Virus Vaccine Serum: 6 Week (IgG) Bleed |
|||
SER71202-1000 | The Native Antigen Company | 1ml | 542.2 EUR |
Yellow Fever Virus Vaccine Serum: 6 Week (IgG) Bleed |
|||
SER71202-500 | The Native Antigen Company | 0.5ml | 354.66 EUR |
Tetanus Toxoid from C. tetani purified, vaccine grade |
|||
AV-9105-25 | Alpha Diagnostics | 25 ug | 489.6 EUR |
VacciGel Direct ELISA for the measurement of Hepatitis B Vaccine (HBsAg) formulated in Alum, 48 tests, Quantitative |
|||
VAC-HBS-50 | Alpha Diagnostics | 1 Kit | 927.6 EUR |
ID-VAC VacciGel Direct ELISA for the identification of Hepatitis B Vaccine (HBsAg) formulated in Alum, 24 tests |
|||
VAC-HBS-VID-24 | Alpha Diagnostics | 1 Kit | 634.8 EUR |
ID-VAC VacciGel Direct ELISA for the identification of Tetanus Toxoid Vaccine (TTX) formulated in Alum, 24 tests |
|||
VAC-TTX-VID-24 | Alpha Diagnostics | 1 Kit | 634.8 EUR |
Vaccinia virus Complement control protein C3 (VACWR025) |
|||
1-CSB-YP302389VAI | Cusabio |
|
|
Description: Recombinant Vaccinia virus Complement control protein C3(VACWR025) expressed in Yeast |
|||
Purified Exotoxin A from P. aeruginosa, vaccine grade |
|||
AV-9150-10 | Alpha Diagnostics | 100 ug | 416.4 EUR |
TDB (Trehalose-6,6-dibehenate) Synthetic vaccine adjuvant |
|||
AV-9015-2 | Alpha Diagnostics | 2 mg | 489.6 EUR |
Yellow Fever Virus Vaccine Serum: 6-month (IgG) bleed |
|||
SER71206-1000 | The Native Antigen Company | 1ml | 542.2 EUR |
Yellow Fever Virus Vaccine Serum: 6-month (IgG) bleed |
|||
SER71206-500 | The Native Antigen Company | 0.5ml | 354.66 EUR |
Japanese Encephalitis Vaccine Serum: 6-Month (IgG) Bleed |
|||
SER71210-1000 | The Native Antigen Company | 1ml | 542.2 EUR |
Japanese Encephalitis Vaccine Serum: 6-Month (IgG) Bleed |
|||
SER71210-500 | The Native Antigen Company | 0.5ml | 354.66 EUR |
ID-VAC VacciGel Direct ELISA for the identification of Diphtheria Toxoid Vaccine (DTX) formulated in Alum, 24 tests |
|||
VAC-DTX-VID-24 | Alpha Diagnostics | 1 Kit | 634.8 EUR |
Squalene (oil-in-water nano emulsion);vaccine adjuvant |
|||
AV-3020-10 | Alpha Diagnostics | 10 ml | 343.2 EUR |
Yellow Fever Virus Vaccine Serum: Pre-Vaccination Bleed |
|||
SER71200-100 | The Native Antigen Company | 0.1ml | 315.25 EUR |
Yellow Fever Virus Vaccine Serum: Pre-Vaccination Bleed |
|||
SER71200-1000 | The Native Antigen Company | 1ml | 542.2 EUR |
Yellow Fever Virus Vaccine Serum: Pre-Vaccination Bleed |
|||
SER71200-500 | The Native Antigen Company | 0.5ml | 354.66 EUR |
Lipopolysaccharides (LPS) (Salmonella typhimurium) vaccine adjuvant |
|||
AV-7020-1 | Alpha Diagnostics | 1 mg | 196.8 EUR |
Lipopolysaccharides (LPS) (Salmonella typhimurium) vaccine adjuvant |
|||
AV-7020-10 | Alpha Diagnostics | 10 mg | 634.8 EUR |
Purified Pasteurella multocida Toxin (146 kda), vaccine grade |
|||
AV-9145-10 | Alpha Diagnostics | 10 ug | 416.4 EUR |
Lipopolysaccharides (LPS) (Escherichia coli 0111:B4) vaccine adjuvant |
|||
AV-7015-1 | Alpha Diagnostics | 1 mg | 196.8 EUR |
Lipopolysaccharides (LPS) (Escherichia coli 0111:B4) vaccine adjuvant |
|||
AV-7015-10 | Alpha Diagnostics | 10 mg | 634.8 EUR |
ID-VAC VacciGel Direct ELISA for the identification of B. Pertussis Toxoid Vaccine (PTX) formulated in Alum, 24 tests |
|||
VAC-PTX-VID-24 | Alpha Diagnostics | 1 Kit | 634.8 EUR |
NATtrol Respiratory Panel 2 (RP2) Controls (Ea) |
|||
NATRPC2-BIO | Zeptometrix | Ea | 550.46 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
Purified CRM197 (Diphtheria Toxin mutant) protein vaccine grade |
|||
AV-9125-100 | Alpha Diagnostics | 100 ug | 416.4 EUR |
QS-21 (Quillaja saponaria), Vaccine adjuvant, (EU GMP grade) >95% |
|||
AV-4010-1 | Alpha Diagnostics | 1 mg | 489.6 EUR |
QS-21 (Quillaja saponaria), Vaccine adjuvant, (EU GMP grade) >95% |
|||
AV-4010-5 | Alpha Diagnostics | 5 mg | 1951.2 EUR |
Japanese Encephalitis Virus Vaccine Serum: Pre-Vaccination Bleed |
|||
SER71207-100 | The Native Antigen Company | 0.1ml | 315.25 EUR |
Japanese Encephalitis Virus Vaccine Serum: Pre-Vaccination Bleed |
|||
SER71207-1000 | The Native Antigen Company | 1ml | 542.2 EUR |
Japanese Encephalitis Virus Vaccine Serum: Pre-Vaccination Bleed |
|||
SER71207-500 | The Native Antigen Company | 0.5ml | 542.2 EUR |
ID-VAC Human Anti-Influenza B Vaccine ELISA kit, 24 tests |
|||
920-FLB-VID-24 | Alpha Diagnostics | 1 Kit | 634.8 EUR |
Vaccigel Alum adjuvant (2% Aluminum hydroxide, ready to use), Vaccine adjuvant |
|||
AV-1010-50 | Alpha Diagnostics | 50 ml | 343.2 EUR |
Monophosphoryl lipid A (MPLA) (Synthetic, TLR4/Th1) vaccine adjuvant |
|||
AV-7030-1 | Alpha Diagnostics | 1 mg | 489.6 EUR |
Monophosphoryl lipid A (MPLA) (Synthetic, TLR4/Th1) vaccine adjuvant |
|||
AV-7030-5 | Alpha Diagnostics | 5 mg | 1365.6 EUR |
Vaccigel Alum adjuvant adsorbed with Ovalbumin (OVA @1 mg/ml), Vaccine adjuvant |
|||
AV-1010-OVA | Alpha Diagnostics | 1 ml | 270 EUR |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Schistosoma mansoni vaccine (Smp-80/GST) by ELISA |
|||
960-190-CUX | Alpha Diagnostics | Custom | Ask for price |
Diphtheria Toxoid/Toxin (DTX) Vaccine ELISA for the measurement DTX in biological buffer, 96 tests, quantitative |
|||
940-DTX-AG1 | Alpha Diagnostics | 1 Kit | 1448.4 EUR |
Vaccigel AlumPhos adjuvant (2% Aluminum phosphate, ready to use), Vaccine adjuvant |
|||
AV-1015-50 | Alpha Diagnostics | 50 ml | 270 EUR |
Saponins vaccine adjuvant Combo Pak-1 (contains 1mg of QS21,100 mg of Vet-SAP and 1 g of Saponin). |
|||
AV-4000-PK-1 | Alpha Diagnostics | 1 pk | 634.8 EUR |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Yellow Fever Virus (YFV) vaccine (ENV/prM/NS1) by ELISA |
|||
530-200-CUX | Alpha Diagnostics | Custom | Ask for price |
HER2 peptide, (776 ? 790 fused with LRMK, C-Term ), GP2 vaccine candidate |
|||
HER2-776-P | Alpha Diagnostics | 5 mg | 343.2 EUR |
Rabbit Anti-HER2 peptide IgG (cyclic 597-626 vaccine candidate) Aff pure |
|||
HER2-597-A | Alpha Diagnostics | 100 ul | 578.4 EUR |
NATtrol Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL) |
|||
NATRPC2.1-BIO | Zeptometrix | 12 x 0.3mL | 529 EUR |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Varicella Zoster Virus (VZV/chickenpox) vaccine by ELISA |
|||
520-200-CUX | Alpha Diagnostics | Custom | Ask for price |
Monophosphoryl lipid A (MPLA)-SM (S. enterica Minnesota, 595),vaccine adjuvant |
|||
AV-7025-5 | Alpha Diagnostics | 5 mg | 1886.4 EUR |
ID-VAC Human Influenza A Vaccine identification ELISA kit, 24 tests |
|||
920-FLA-VID-24 | Alpha Diagnostics | 1 Kit | 634.8 EUR |
HER2 peptide, cyclic, (563-598, cys-cys disulphide bond); vaccine candidate |
|||
HER2-563-P | Alpha Diagnostics | 5 mg | 562.8 EUR |
HER2 peptide, cyclic, (585-598, cys-cys disulphide bond); vaccine candidate |
|||
HER2-585-P | Alpha Diagnostics | 5 mg | 416.4 EUR |
HER2 peptide, cyclic, (597-626, cys-cys disulphide bond) vaccine candidate |
|||
HER2-597-P | Alpha Diagnostics | 5 mg | 489.6 EUR |
HER2 peptide, cyclic, (613-626, cys-cys disulphide bond); vaccine candidate |
|||
HER2-613-P | Alpha Diagnostics | 5 mg | 416.4 EUR |
Single Donor Human SARS-CoV-2 Positive With Vaccine Positive Serum |
|||
ISERSCOV2VPP | Innovative research | each | 209 EUR |
Description: Single Donor Human SARS-CoV-2 Positive With Vaccine Positive Serum |
|||
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Respiratory syncytial virus (RSV) vaccine (RSV-F) by ELISA |
|||
510-190-CUX | Alpha Diagnostics | Custom | Ask for price |
Vaccigel Alum adjuvant adsorbed with Lipopolysaccharide (LPS @1 mg/ml), Vaccine adjuvant |
|||
AV-1010-LPS | Alpha Diagnostics | 1 ml | 489.6 EUR |
Single Donor Human SARS-CoV-2 Positive With Vaccine Positive Plasma |
|||
IPLASCOV2VPP | Innovative research | each | 209 EUR |
Description: Single Donor Human SARS-CoV-2 Positive With Vaccine Positive Plasma |
|||
Rabbit Anti-West Nile Virus (WNV vaccine/Innovator, inactivated) antiserum |
|||
WNV12-S | Alpha Diagnostics | 100 ul | 548.4 EUR |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Meninigitis B Vaccine Proteins (NadA/fHBP/NHBA/PorA) by ELISA |
|||
600-900-CUX | Alpha Diagnostics | Custom | Ask for price |
Monophosphoryl lipid A (MPLA)-SM (S. enterica Minnesota, R595),vaccine adjuvant |
|||
AV-7025-1 | Alpha Diagnostics | 1 mg | 562.8 EUR |
Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to B. pertussis vaccine (Toxin/Toxoid/LPS/FHA/PRN/Fim2/3) by ELISA |
|||
960-100-CUX | Alpha Diagnostics | Custom | Ask for price |
Vaccigel Alum adjuvant adsorbed with Bovine Serum Albumin (BSA @1 mg/ml), Vaccine adjuvant |
|||
AV-1010-BSA | Alpha Diagnostics | 1 ml | 343.2 EUR |
Rabbit Anti-HER2 peptide IgG (cyclic 367-37; E75 vaccine candidate) Aff pure |
|||
HER2-369-A | Alpha Diagnostics | 100 ul | 578.4 EUR |
Human Anti-Her2 vaccine (E75-peptide) IgG ELISA kit, 96 tests, Quantitative |
|||
200-640-HRH | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Human Anti-Her2 vaccine (E75-peptide) IgM ELISA kit, 96 tests, Quantitative |
|||
200-650-HRM | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Mouse Anti-Her2 vaccine (E75-peptide) IgG ELISA kit, 96 tests, Quantitative |
|||
200-660-HRH | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Mouse Anti-Her2 vaccine (AE37-peptide) IgM ELISA kit, 96 tests, Quantitative |
|||
200-670-HRM | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Human Anti-Her2 vaccine (AE37-peptide) IgG ELISA kit, 96 tests, Quantitative |
|||
200-700-HRH | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Human Anti-Her2 vaccine (AE37-peptide) IgM ELISA kit, 96 tests, Quantitative |
|||
200-710-HRM | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Mouse Anti-Her2 vaccine (AE37-peptide) IgG ELISA kit, 96 tests, Quantitative |
|||
200-720-HRH | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Mouse Anti-Her2 vaccine (AE37-peptide) IgM ELISA kit, 96 tests, Quantitative |
|||
200-730-HRM | Alpha Diagnostics | 1 Kit | 927.6 EUR |
Recombinant YFV NS4A Protein (aa 1-3411) (strain French neurotropic vaccine FNV) |
|||
VAng-Cr6552-inquire | Creative Biolabs | inquire | Ask for price |
Description: YFV (strain French neurotropic vaccine FNV) Genome polyprotein (NS4A), recombinant protein. |
|||
Purified Recombinant Anthrax Protective Antigen (83 kD) (Non toxic), vaccine grade |
|||
AV-9140-100 | Alpha Diagnostics | 100 ug | 781.2 EUR |
Purified Recombinant Anthrax Protective Antigen (83 kD) (Non toxic), vaccine grade |
|||
AV-9140-1000 | Alpha Diagnostics | 1 mg | 2910 EUR |
Rabbit Anti-Zaire Ebola virus nucleoprotein (EBOV NP, 1-739/DNA vaccine) IgG |
|||
EVNP13-A | Alpha Diagnostics | 100 ul | 578.4 EUR |
Mumps virus (strain Miyahara vaccine) (MuV) HN Protein, His Tag (MALS & SPR verified) |
|||
HNN-M52H3 | ACROBIOSYSTEMS | 500ug | 481.5 EUR |
Description: Mumps virus (strain Miyahara vaccine) (MuV) HN Protein, His Tag (HNN-M52H3) is expressed from human 293 cells (HEK293). It contains AA Gly 106 - Thr 582 (Accession # P11235). |
|||
Lipopolysaccharides (LPS) (Escherichia coli 0111:B4) vaccine adjuvant, ultrapure, TLR4 tested |
|||
AV-7016-1 | Alpha Diagnostics | 1 mg | 196.8 EUR |
Lipopolysaccharides (LPS) (Escherichia coli 0111:B4) vaccine adjuvant, ultrapure, TLR4 tested |
|||
AV-7016-5 | Alpha Diagnostics | 5 mg | 416.4 EUR |
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring a number of NNRTI resistance mutations
Targets: Doravirine is a not too long ago licensed HIV-1 NNRTI with improved efficacy, pharmacokinetics and security profile in contrast with efavirenz and restricted cross-resistance with rilpivirine and etravirine. On this in vitro research, cross-resistance to doravirine was analysed in a consultant panel of NNRTI-resistant clones.
Strategies: In vitro phenotypic susceptibility to doravirine was assessed in 10 clinically derived infectious clones with intermediate- to high-level resistance to rilpivirine, etravirine, efavirenz and nevirapine, and in NL4-Three site-directed mutants harbouring Ok103N, Y181C, M230L or Ok103N/Y181C NNRTI mutations
Outcomes: Though not one of the infectious clones harboured any of the most important doravirine resistance-associated mutations (RAMs) included within the IAS-USA reference listing, doravirine fold change (FC) values have been corresponding to or larger than these calculated for different NNRTIs, significantly etravirine and rilpivirine.
As anticipated, single NNRTI mutations Ok103N and Y181C didn’t impair doravirine susceptibility (FC 1.Four and 1.8, respectively), whereas decreased exercise was noticed with the only M230L or double Ok103N/Y181C mutations (FC 7.6 and 4.9, respectively). Median FC values elevated considerably with growing numbers of NNRTI RAMs (P = 0.005) and have been >10 in 4/Four and 1/Four clones harbouring 4 and three NNRTI RAMs, respectively. FC values correlated nicely with predicted susceptibility as inferred by Stanford HIV Drug Resistance Database (HIVdb) and ANRS algorithms (each P < 0.001).
Conclusions: Substantial cross-resistance to doravirine was detected in NNRTI-resistant viruses harbouring complicated mutational patterns, even within the absence of main IAS-USA doravirine RAMs. Due to this fact, primarily based on the straightforward IAS-USA reference listing, doravirine resistance could also be underestimated in viruses harbouring a number of NNRTI mutations.
Affiliation between modifications in financial exercise and catastrophic well being expenditure: findings from the Korea Well being Panel Survey, 2014-2016
Background: The speed of catastrophic well being expenditure (CHE) continues to rise in South Korea. This research examined the affiliation between modifications in financial exercise and CHE experiences in South Korea.
Strategies: This research analyzed the Korea Well being Panel Survey information utilizing a logistic regression evaluation to check the affiliation between modifications in financial exercise in 2014-2015 and the members’ CHE experiences in 2015. The research included a complete of 12,454 people over the age of 19. The subgroup analyses have been organized by intercourse, age, health-related variables, and family degree variables, and the explanations for leaving financial exercise.
Outcomes: Those that stop financial actions have been extra more likely to expertise CHE than those that continued to have interaction in financial actions (OR [odds ratio] = 2.10; 95% CI [confidence interval]: 1.31-3.36). The subgroup evaluation outcomes, in accordance with health-related variables, confirmed that there’s a tendency to the next Charlson comorbidity index, the next OR, and, in teams that stop their financial actions, folks with disabilities have been extra more likely to expertise CHE than folks with out disabilities (OR = 5.63; 95% CI 1.71-18.59, OR = 1.82; 95% CI 1.08-3.08, respectively).
One other subgroup evaluation discovered that if the explanation for not taking part in financial exercise was a health-related concern, the participant was extra more likely to expertise CHE (energetic → inactive: OR = 2.40; 95% CI 0.61-9.43, inactive → inactive OR = 1.65; 95% CI 1.01-2.68).
Conclusions: These people who turned unemployed have been extra more likely to expertise CHE, particularly if well being issues precipitated the job loss. Due to this fact, efforts are wanted to develop protection for these individuals who undergo from excessive medical bills.
SeroDetect HIV-Ab Verification Panel (5 X 1.5 mL) |
|||
KZMC006 | Zeptometrix | 5 X 1.5 mL | 286 EUR |
SeroDetect Anti-HBs Verification Panel (6 X 1.5 mL) |
|||
KZMC008 | Zeptometrix | 6 X 1.5 mL | 286 EUR |
SeroDetect Anti-HCV Verification Panel (5 X 1.5 mL) |
|||
KZMC010 | Zeptometrix | 5 X 1.5 mL | 286 EUR |
SeroDetect Dengue Fever Verification Panel (9 X 0.5 mL) |
|||
KZMC028 | Zeptometrix | 10 X 0.5 mL | 277 EUR |
SeroDetect Anti-HBcore Verification Panel (5 X 1.5 mL) |
|||
KZMC009 | Zeptometrix | 5 X 1.5 mL | 334.56 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
SeroDetect HIV-Ab Range Verification Panel (10 X 1.5 mL) |
|||
KZMC024 | Zeptometrix | 10 X 1.5 mL | 286 EUR |
SeroDetect West Nile Virus Verification Panel (10 X 0.5 mL) |
|||
KZMC027 | Zeptometrix | 10 X 0.5 mL | 334.56 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
SeroDetect HCV-Ab Mixed Titer Verification Panel I (15 X 0.25 mL) |
|||
KZMC022 | Zeptometrix | 15 X 0.25 mL | 269 EUR |
SeroDetect HIV-1/ HIV-2 Ag/Ab Combo Verification Panel (5 X 1.25mL) |
|||
KZMC030 | Zeptometrix | 5 X 1.25mL | 328 EUR |
Recombinant purified Hepatitis Surface Antigen (HBsAg) protein control for WB |
|||
HBA11-C | Alpha Diagnostics | 100 ul | 343.2 EUR |
Core Panel Multi-Tumor control slides, set of 5 |
|||
TS900 | Innovex | Set of 5 | 145 EUR |
Description: Core Panel Multi-Tumor control slides, set of 5 |
|||
Core Panel Multi-Tumor control slides, set of 25 |
|||
TS900-25 | Innovex | Set of 25 | 425 EUR |
Description: Core Panel Multi-Tumor control slides, set of 25 |
|||
Breast Panel Multi-Tumor control slides, set of 5 |
|||
TS901 | Innovex | Set of 5 | 145 EUR |
Description: Breast Panel Multi-Tumor control slides, set of 5 |
|||
Breast Panel Multi-Tumor control slides, set of 25 |
|||
TS901-25 | Innovex | Set of 25 | 395 EUR |
Description: Breast Panel Multi-Tumor control slides, set of 25 |
|||
Hepatitis B Surface Antigen (HBsAg) pre-S1 peptide control/blocking peptide |
|||
HBVS12-P | Alpha Diagnostics | 100 ug | 270 EUR |
Hepatitis B Surface Antigen (HBsAg) pre-S2 (55-aa) control/blocking peptide |
|||
HBVS23-P | Alpha Diagnostics | 100 ug | 270 EUR |
NATtrol Respiratory Panel 2 (RP2) Controls (Ea) |
|||
NATRPC2-BIO | Zeptometrix | Ea | 550.46 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
NATtrol Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL) |
|||
NATRPC2.1-BIO | Zeptometrix | 12 x 0.3mL | 529 EUR |
HBsAg |
|||
ant-194 | ProSpec Tany | 2µg | 60 EUR |
Description: Recombinant Anti Hepatitis B Virus Surface Antigen Ck |
|||
HBsAg |
|||
ant-773 | ProSpec Tany | 100µg | 200 EUR |
Description: Mouse Anti Hepatitis B Surface Antigen |
|||
HBsAg Serum Test Card |
|||
HBsAg-212 | Innovation Biotech | 4.0mm (strip in a card) 25cards/box | 0.16 EUR |
HBsAg ayw |
|||
hbs-870 | ProSpec Tany | 10µg | 60 EUR |
Description: Recombinant Hepatitis B Surface Antigen ayw subtype, Saccharomyces |
|||
HBsAg adw |
|||
hbs-872 | ProSpec Tany | 20µg | 60 EUR |
Description: Recombinant Hepatitis B Surface Antigen Adw subtype |
|||
HBsAg ayw |
|||
hbs-877 | ProSpec Tany | 10µg | 60 EUR |
Description: Recombinant Hepatitis B Surface Antigen ayw subtype |
|||
HBsAg Serum Test Strip |
|||
HBsAg-211 | Innovation Biotech | 3.0mm (single pouch) 100pouches/box | 0.08 EUR |
HBsAg adw2 |
|||
hbs-885 | ProSpec Tany | 10µg | 60 EUR |
Description: Recombinant Hepatitis B Surface Antigen Adw2 subtype |
|||
HBsAg preS1 |
|||
hbs-871 | ProSpec Tany | 10µg | 55 EUR |
Description: Recombinant Hepatitis B Surface Antigen preS1 |
|||
HBsAg preS2 |
|||
hbs-874 | ProSpec Tany | 10µg | 55 EUR |
Description: Recombinant Hepatitis B Surface Antigen preS2 |
|||
HBsAg Paired |
|||
ant-650 | ProSpec Tany | 100µg | 165 EUR |
Description: Mouse Anti Hepatitis B Surface Antigen Paired |
|||
HBsAg Protein |
|||
abx060551-1mg | Abbexa | 1 mg | 1863.6 EUR |
HBsAg Protein |
|||
abx060552-1mg | Abbexa | 1 mg | 1212 EUR |
HBsAg Protein |
|||
abx060560-1mg | Abbexa | 1 mg | 1345.2 EUR |
HBsAg Protein |
|||
abx060562-1mg | Abbexa | 1 mg | 1880.4 EUR |
HBsAg antibody |
|||
10-1323 | Fitzgerald | 1 mg | 163.2 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-1324 | Fitzgerald | 1 mg | 163.2 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-3128 | Fitzgerald | 1 mg | 276 EUR |
Description: Mouse Monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-3130 | Fitzgerald | 1 mg | 276 EUR |
Description: Mouse Monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-3131 | Fitzgerald | 1 mg | 276 EUR |
Description: Mouse Monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-7857 | Fitzgerald | 1 mg | 376.8 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-7858 | Fitzgerald | 1 mg | 367.2 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H05A | Fitzgerald | 1 mg | 264 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H05B | Fitzgerald | 1 mg | 264 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H05C | Fitzgerald | 1 mg | 710.4 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H05D | Fitzgerald | 1 mg | 264 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H05F | Fitzgerald | 1 mg | 264 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H05G | Fitzgerald | 1 mg | 273.6 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H05H | Fitzgerald | 1 mg | 273.6 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H05J | Fitzgerald | 1 mg | 230.4 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H05N | Fitzgerald | 1 mg | 264 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H114C | Fitzgerald | 1 mg | 403.2 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-H114D | Fitzgerald | 1 mg | 390 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10C-CR1279M1 | Fitzgerald | 100 ug | 337.2 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10R-H114c | Fitzgerald | 1 mg | 586.8 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10R-H114d | Fitzgerald | 1 mg | 566.4 EUR |
Description: Mouse monoclonal HBsAg antibody |
|||
HbsAg antibody |
|||
20R-2830 | Fitzgerald | 1 ml | 678 EUR |
Description: Goat polyclonal HbsAg antibody |
|||
HBsAg antibody |
|||
20C-CR2100G | Fitzgerald | 1 ml | 159.6 EUR |
Description: Goat polyclonal HBsAg antibody |
|||
HBsAg antibody |
|||
20C-CR2100GP | Fitzgerald | 1 ml | 512.4 EUR |
Description: Goat polyclonal HBsAg antibody |
|||
HBsAg antibody |
|||
20-HR20 | Fitzgerald | 1 mg | 404.4 EUR |
Description: Rabbit polyclonal HBsAg antibody |
|||
HBsAg antibody |
|||
70R-HG003 | Fitzgerald | 1 mg | 295.2 EUR |
Description: Goat polyclonal HBsAg antibody |
|||
HBsAg antibody |
|||
70-1088 | Fitzgerald | 1 mg | 262.8 EUR |
Description: Goat polyclonal HBsAg antibody |
|||
HBsAg antibody |
|||
70-HH15 | Fitzgerald | 1 mg | 309.6 EUR |
Description: Horse polyclonal HBsAg antibody |
|||
HBsAg antibody |
|||
10-2875 | Fitzgerald | 1 mg | 200 EUR |
Description: Monoclonal anti-HBsAg antibody |
|||
HBsAg Antibody |
|||
E3M00015 | EnoGene | 200ul | 275 EUR |
Description: Available in various conjugation types. |
|||
CleanPlex for MGI SARS-CoV-2 Panel (384) |
|||
918003 | BioServUK | 384 reactions | Ask for price |
Description: CleanPlex for MGI SARS-CoV-2 Panel (384) |
|||
HBsAg adw CHO |
|||
hbs-001 | ProSpec Tany | 100µg | 200 EUR |
Description: Recombinant Hepatitis B Surface Antigen Adw subtype, CHO |
|||
HBsAg adr CHO |
|||
hbs-875 | ProSpec Tany | 20µg | 60 EUR |
Description: Recombinant Hepatitis B Surface Antigen adr subtype, CHO |
|||
ELISA kit for Human HBsAg (Hepatitis B surface antigen) |
|||
E-EL-H1567 | Elabscience Biotech | 1 plate of 96 wells | 640.8 EUR |
Description: A sandwich ELISA kit for quantitative measurement of Human HBsAg (Hepatitis B surface antigen) in samples from Serum, Plasma, Cell supernatant |
|||
HBsAg ad Protein |
|||
abx060555-100ug | Abbexa | 100 ug | 1053.6 EUR |
HBsAg ay Protein |
|||
abx060563-100ug | Abbexa | 100 ug | 978 EUR |
HBsAg adr Protein |
|||
abx060556-05mg | Abbexa | 0.5 mg | 1880.4 EUR |
HBsAg adw Protein |
|||
abx060557-01mg | Abbexa | 0.1 mg | 1220.4 EUR |
HBsAg adw Protein |
|||
abx060558-05mg | Abbexa | 0.5 mg | 1554 EUR |
HBsAg ayw Protein |
|||
abx060565-05mg | Abbexa | 0.5 mg | 1629.6 EUR |
HBsAg ayw Protein |
|||
abx060566-05mg | Abbexa | 0.5 mg | 1796.4 EUR |
HBsAg adw Protein |
|||
abx060567-1mg | Abbexa | 1 mg | 1220.4 EUR |
Zika Virus Seroconversion Panel (7 X 0.5mL) |
|||
KZMC047 | Zeptometrix | 7 X 0.5mL | 2890 EUR |
HBsAg antibody (HRP) |
|||
60C-CR2100GX | Fitzgerald | 1 ml | 541.2 EUR |
Description: Goat polyclonal HBsAg antibody (HRP) conjugated |
|||
HBsAg antibody (HRP) |
|||
60C-CR2100RX | Fitzgerald | 1 ml | 534 EUR |
Description: Rabbit polyclonal HBsAg antibody (HRP) conjugated |
|||
Human HBsAg Protein |
|||
abx060118-1mg | Abbexa | 1 mg | 493.2 EUR |
HBsAg antibody (FITC) |
|||
60C-CR2100GF | Fitzgerald | 1 ml | 435.6 EUR |
Description: Goat polyclonal HBsAg antibody (FITC) conjugated |
|||
HBsAg antibody (FITC) |
|||
60C-CR2100RF | Fitzgerald | 1 ml | 462 EUR |
Description: Rabbit polyclonal HBsAg antibody (FITC) conjugated |
|||
Eppendorf Centrifuge 5430R Knob Control Refrigerated- IVD Only |
|||
E5428000465 | Scientific Laboratory Supplies | EACH | 8115.6 EUR |
HIV Seroconversion Panel Donor# 65404 (7 X mL) |
|||
HIV9013 | Zeptometrix | 7 X mL | 1764 EUR |
HBsAg antibody (biotin) |
|||
61-1066 | Fitzgerald | 1 ml | 159.6 EUR |
Description: Mouse monoclonal HBsAg antibody (biotin-conjugated) |
|||
HBsAg antibody (biotin) |
|||
60C-CR2100GB | Fitzgerald | 1 ml | 548.4 EUR |
Description: Goat polyclonal HBsAg antibody (biotin) conjugated |
|||
HBsAg antibody (biotin) |
|||
60C-CR2100RB | Fitzgerald | 1 ml | 543.6 EUR |
Description: Rabbit polyclonal HBsAg antibody (biotin) conjugated |
|||
HBsAg adw1 24 kDa |
|||
PR-1402-L | Jena Bioscience GmbH | 1mg | 1789.2 EUR |
Description: recombinant, Pichia pastoris |
|||
HBsAg adw1 24 kDa |
|||
PR-1402-S | Jena Bioscience GmbH | 200µg | 447.3 EUR |
Description: recombinant, Pichia pastoris |
|||
ELISA kit for Human Hepatitis B surface antigen (HBsAg) Kit |
|||
KTE63050-48T | Abbkine | 48T | 424.8 EUR |
Description: Quantitative sandwich ELISA for measuring Human Hepatitis B surface antigen (HBsAg) Kit in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Hepatitis B surface antigen (HBsAg) Kit |
|||
KTE63050-5platesof96wells | Abbkine | 5 plates of 96 wells | 2702.4 EUR |
Description: Quantitative sandwich ELISA for measuring Human Hepatitis B surface antigen (HBsAg) Kit in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Hepatitis B surface antigen (HBsAg) Kit |
|||
KTE63050-96T | Abbkine | 96T | 686.4 EUR |
Description: Quantitative sandwich ELISA for measuring Human Hepatitis B surface antigen (HBsAg) Kit in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
CleanPlex for MGI SARS-CoV-2 Panel (8) |
|||
918001 | BioServUK | 8 reactions | Ask for price |
Description: CleanPlex for MGI SARS-CoV-2 Panel (8) |
|||
CleanPlex for MGI SARS-CoV-2 Panel (96) |
|||
918002 | BioServUK | 96 reactions | Ask for price |
Description: CleanPlex for MGI SARS-CoV-2 Panel (96) |
|||
ELISA kit for Human hepatitis B virus surface antigen,HBsAg |
|||
EK0216 | SAB | 96 tests | 723.6 EUR |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human hepatitis B virus surface antigen,HBsAg in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
ELISA kit for Mouse hepatitis B virus surface antigen,HBsAg |
|||
EK0341 | SAB | 96 tests | 996 EUR |
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse hepatitis B virus surface antigen,HBsAg in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
Rat HBsAg ELISA Kit |
|||
ERH0214 | Abclonal | 96Tests | 625.2 EUR |
HCV Seroconversion Panel Donor# 63625 (8 X 1 mL) |
|||
HCV9041 | Zeptometrix | 8 X 1 mL | 1764 EUR |
HCV Seroconversion Panel Donor# 63792 (6 X 1 mL) |
|||
HCV9042 | Zeptometrix | 6 X 1 mL | 1035 EUR |
HCV Seroconversion Panel Donor# 63869 (6 X 1 mL) |
|||
HCV9043 | Zeptometrix | 6 X 1 mL | 1035 EUR |
HCV Seroconversion Panel Donor# 63911 (6 X 1 mL) |
|||
HCV9044 | Zeptometrix | 6 X 1 mL | 1764 EUR |
HCV Seroconversion Panel Donor# 64150 (8 X 1 mL) |
|||
HCV9045 | Zeptometrix | 8 X 1 mL | 1764 EUR |
HCV Seroconversion Panel Donor# 64254 (5 X 1 mL) |
|||
HCV9046 | Zeptometrix | 5 X 1 mL | 1764 EUR |
HCV Seroconversion Panel Donor# 64273 (10 X 1 mL) |
|||
HCV9047 | Zeptometrix | 10 X 1 mL | 1764 EUR |
HCV Seroconversion Panel Donor# 64437 (8 X 1 mL) |
|||
HCV9048 | Zeptometrix | 8 X 1 mL | 1035 EUR |
HCV Seroconversion Panel Donor# 1038851 (5 X 1 mL) |
|||
HCV9095 | Zeptometrix | 5 X 1 mL | 1764 EUR |
EBV Seroconversion Panel Donor# 283843421 (14 X 1 mL) |
|||
EBV9097 | Zeptometrix | 14 X 1 mL | 1764 EUR |
HCV Seroconversion Panel Donor# 61025 (5 X 1 mL) |
|||
HCV6217 | Zeptometrix | 5 X 1 mL | 1035 EUR |
HCV Seroconversion Panel Donor# 61251 (8 X 1 mL) |
|||
HCV6218 | Zeptometrix | 8 X 1 mL | 1035 EUR |
HCV Seroconversion Panel Donor# 60749 (14 X 1 mL) |
|||
HCV6219 | Zeptometrix | 14 X 1 mL | 1035 EUR |
HCV Seroconversion Panel Donor# 63792 (6 X 1 mL) |
|||
HCV6220 | Zeptometrix | 6 X 1 mL | 1035 EUR |
HCV Seroconversion Panel Donor# 62258 (8 X 1 mL) |
|||
HCV6221 | Zeptometrix | 8 X 1 mL | 1035 EUR |
HCV Seroconversion Panel Donor# 62286 (8 X 1 mL) |
|||
HCV6222 | Zeptometrix | 8 X 1 mL | 1764 EUR |
HCV Seroconversion Panel Donor# 62507 (22 X 1 mL) |
|||
HCV6223 | Zeptometrix | 22 X 1 mL | 1035 EUR |
HCV Seroconversion Panel Donor# 62680 (6 X 1 mL) |
|||
HCV6224 | Zeptometrix | 6 X 1 mL | 1764 EUR |
HCV Seroconversion Panel Donor# 62999 (19 X 1 mL) |
|||
HCV6225 | Zeptometrix | 19 X 1 mL | 1764 EUR |
HCV Seroconversion Panel Donor# 63135 (12 X 1 mL) |
|||
HCV6226 | Zeptometrix | 12 X 1 mL | 1764 EUR |
HCV Seroconversion Panel Donor# 63318 (7 X 1 mL) |
|||
HCV6227 | Zeptometrix | 7 X 1 mL | 1764 EUR |
HCV Seroconversion Panel Donor# 62886 (12 X 1 mL) |
|||
HCV6228 | Zeptometrix | 12 X 1 mL | 1764 EUR |
HCV Seroconversion Panel Donor# 62804 (8 X 1 mL) |
|||
HCV6229 | Zeptometrix | 8 X 1 mL | 1764 EUR |
HCV Seroconversion Panel Donor# 64766 (5 X 1 mL) |
|||
HCV9049 | Zeptometrix | 5 X 1 mL | 1035 EUR |
HCV Seroconversion Panel Donor# 66158 (13 X 1 mL) |
|||
HCV9050 | Zeptometrix | 13 X 1 mL | 1764 EUR |
HCV Seroconversion Panel Donor# 66626 (8 X 1 mL) |
|||
HCV9054 | Zeptometrix | 8 X 1 mL | 1764 EUR |
HCV Seroconversion Panel Donor# 66732 (11 X 1 mL) |
|||
HCV9055 | Zeptometrix | 11 X 1 mL | 1764 EUR |
HCV Seroconversion Panel Donor# 66861 (11 X 1 mL) |
|||
HCV9057 | Zeptometrix | 11 X 1 mL | 1764 EUR |
HCV Seroconversion Panel Donor# 66647 (5 X 1 mL) |
|||
HCV9058 | Zeptometrix | 5 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 73695 (9 X 1 mL) |
|||
HIV12007 | Zeptometrix | 9 X 1 mL | 2344 EUR |
HIV Seroconversion Panel Donor# 73698 (13 X 1 mL) |
|||
HIV12008 | Zeptometrix | 13 X 1 mL | 2344 EUR |
HIV Seroconversion Panel Donor# 63331 (7 X 1 mL) |
|||
HIV6248 | Zeptometrix | 7 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 64954 (11 X 1 mL) |
|||
HIV9011 | Zeptometrix | 11 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 65389 (8 X 1 mL) |
|||
HIV9012 | Zeptometrix | 8 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 65522 (5 X 1 mL) |
|||
HIV9014 | Zeptometrix | 5 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 65661 (6 X 1 mL) |
|||
HIV9015 | Zeptometrix | 6 X 1 mL | 1858.37 EUR |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
HIV Seroconversion Panel Donor# 65790 (10 X 1 mL) |
|||
HIV9016 | Zeptometrix | 10 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 66575 (10 X 1 mL) |
|||
HIV9018 | Zeptometrix | 10 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 65685 (3 X 1 mL) |
|||
HIV9019 | Zeptometrix | 3 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 67512 (22 X 1 mL) |
|||
HIV9020 | Zeptometrix | 22 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 67485 (17 X 1 mL) |
|||
HIV9021 | Zeptometrix | 17 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 64578 (8 X 1 mL) |
|||
HIV9022 | Zeptometrix | 8 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 67706 (22 X 1 mL) |
|||
HIV9023 | Zeptometrix | 22 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 64469 (12 X 1 mL) |
|||
HIV9024 | Zeptometrix | 12 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 67996 (12 X 1 mL) |
|||
HIV9025 | Zeptometrix | 12 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 68205 (7 X 1 mL) |
|||
HIV9026 | Zeptometrix | 7 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 67860 (7 X 1 mL) |
|||
HIV9028 | Zeptometrix | 7 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 68262 (12 X 1 mL) |
|||
HIV9029 | Zeptometrix | 12 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 68582 (16 X 1 mL) |
|||
HIV9030 | Zeptometrix | 16 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 66048 (19 X 1 mL) |
|||
HIV9031 | Zeptometrix | 19 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 66686 (16 X 1 mL) |
|||
HIV9033 | Zeptometrix | 16 X 1 mL | 1764 EUR |
HIV Seroconversion Panel Donor# 66632 (13 X 1 mL) |
|||
HIV9034 | Zeptometrix | 13 X 1 mL | 1764 EUR |
HBV Seroconversion Panel Donor# 64090 (5 X 1 mL) |
|||
HBV10231 | Zeptometrix | 5 X 1 mL | 627 EUR |
HBV Seroconversion Panel Donor# 64017 (6 X 1 mL) |
|||
HBV10232 | Zeptometrix | 6 X 1 mL | 627 EUR |
HBV Seroconversion Panel Donor# 65449 (9 X 1 mL) |
|||
HBV11000 | Zeptometrix | 9 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 65524 (8 X 1 mL) |
|||
HBV11001 | Zeptometrix | 8 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 65556 (6 X 1 mL) |
|||
HBV11002 | Zeptometrix | 6 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 65584 (8 X 1 mL) |
|||
HBV11003 | Zeptometrix | 8 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 65732 (8 X 1 mL) |
|||
HBV11004 | Zeptometrix | 8 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 65777 (14 X 1 mL) |
|||
HBV11005 | Zeptometrix | 14 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 66201 (17 X 1 mL) |
|||
HBV11006 | Zeptometrix | 17 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 66537 (14 X 1 mL) |
|||
HBV11007 | Zeptometrix | 14 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 67303 (18 X 1 mL) |
|||
HBV11008 | Zeptometrix | 18 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 67449 (23 X 1 mL) |
|||
HBV11009 | Zeptometrix | 23 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 67457 (18 X 1 mL) |
|||
HBV11010 | Zeptometrix | 18 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 67694 (14 X 1 mL) |
|||
HBV11011 | Zeptometrix | 14 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 67773 (6 X 1 mL) |
|||
HBV11012 | Zeptometrix | 6 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 67962 (35 X 1 mL) |
|||
HBV11013 | Zeptometrix | 35 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 68029 (12 X 1 mL) |
|||
HBV11014 | Zeptometrix | 12 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 68105 (14 X 1 mL) |
|||
HBV11015 | Zeptometrix | 14 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 68541 (10 X 1 mL) |
|||
HBV11016 | Zeptometrix | 10 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 68739 (14 X 1 mL) |
|||
HBV11017 | Zeptometrix | 14 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 70793 (14 X 1 mL) |
|||
HBV11024 | Zeptometrix | 14 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 70970 (16 X 1 mL) |
|||
HBV11026 | Zeptometrix | 16 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 71415 (13 X 1 mL) |
|||
HBV11027 | Zeptometrix | 13 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 71840 (10 X 1 mL) |
|||
HBV11028 | Zeptometrix | 10 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 69751 (13 X 1 mL) |
|||
HBV11029 | Zeptometrix | 13 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 70292 (15 X 1 mL) |
|||
HBV11031 | Zeptometrix | 15 X 1 mL | 953 EUR |
HBV Seroconversion Panel Donor# 72439 (13 X 1 mL) |
|||
HBV11052 | Zeptometrix | 13 X 1 mL | 953 EUR |